ValiRx (VAL) Competitors GBX 0.47 -0.03 (-6.40%) As of 11:55 AM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsHeadlinesBuy This Stock VAL vs. HNR, EOG, SUN, WRES, EQT, CRC, WEB, NBL, FTO, and TXOShould you be buying ValiRx stock or one of its competitors? The main competitors of ValiRx include Highlands Natural Resources (HNR), Europa Oil & Gas (EOG), Surgical Innovations Group (SUN), W Resources (WRES), EQTEC (EQT), Circle Property (CRC), Webis (WEB), 18564 (NBL.L) (NBL), 2059984 (FTO.L) (FTO), and 282082 (TXO.L) (TXO). These companies are all part of the "petroleum and natural gas" industry. ValiRx vs. Highlands Natural Resources Europa Oil & Gas Surgical Innovations Group W Resources EQTEC Circle Property Webis 18564 (NBL.L) 2059984 (FTO.L) 282082 (TXO.L) Highlands Natural Resources (LON:HNR) and ValiRx (LON:VAL) are both small-cap energy companies, but which is the better stock? We will compare the two businesses based on the strength of their risk, dividends, institutional ownership, earnings, valuation, media sentiment, profitability, community ranking and analyst recommendations. Which has preferable valuation & earnings, HNR or VAL? Highlands Natural Resources has higher revenue and earnings than ValiRx. ValiRx is trading at a lower price-to-earnings ratio than Highlands Natural Resources, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioHighlands Natural Resources£1.02M0.00N/A-£4.90N/AValiRx£27.78K63.96-£5.71M-£1.48-0.32 Is HNR or VAL more profitable? Highlands Natural Resources has a net margin of 0.00% compared to ValiRx's net margin of -20,554.01%. Highlands Natural Resources' return on equity of 0.00% beat ValiRx's return on equity.Company Net Margins Return on Equity Return on Assets Highlands Natural ResourcesN/A N/A N/A ValiRx -20,554.01%-55.84%-35.98% Does the media prefer HNR or VAL? In the previous week, ValiRx had 1 more articles in the media than Highlands Natural Resources. MarketBeat recorded 1 mentions for ValiRx and 0 mentions for Highlands Natural Resources. Highlands Natural Resources' average media sentiment score of 0.00 beat ValiRx's score of -0.95 indicating that Highlands Natural Resources is being referred to more favorably in the media. Company Overall Sentiment Highlands Natural Resources Neutral ValiRx Negative Does the MarketBeat Community favor HNR or VAL? ValiRx received 109 more outperform votes than Highlands Natural Resources when rated by MarketBeat users. However, 58.57% of users gave Highlands Natural Resources an outperform vote while only 51.55% of users gave ValiRx an outperform vote. CompanyUnderperformOutperformHighlands Natural ResourcesOutperform Votes4158.57% Underperform Votes2941.43% ValiRxOutperform Votes15051.55% Underperform Votes14148.45% SummaryHighlands Natural Resources beats ValiRx on 6 of the 10 factors compared between the two stocks. Get ValiRx News Delivered to You Automatically Sign up to receive the latest news and ratings for VAL and its competitors with MarketBeat's FREE daily newsletter. Email Address Media Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart VAL vs. The Competition Export to ExcelMetricValiRxBiotechnology IndustryMedical SectorLON ExchangeMarket Cap£1.78M£125.34M£5.55B£2.59BDividend Yield0.63%3.69%5.09%4.97%P/E Ratio-0.323.2722.75133.69Price / Sales63.964,270.64403.97239,757.82Price / Cash62.5013.0238.1828.12Price / Book0.1834.216.794.55Net Income-£5.71M-£90.45M£3.22B£5.84B7 Day Performance-8.24%1.40%2.30%3.43%1 Month Performance-6.21%4.51%3.64%10.59%1 Year Performance-85.82%94.45%16.87%117.06% ValiRx Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)VALValiRxN/AGBX 0.47-6.4%N/A-83.8%£1.78M£27,777.32-0.325,450HNRHighlands Natural ResourcesN/AN/AN/AN/A£6.95M£1.02M-0.9616Gap DownHigh Trading VolumeEOGEuropa Oil & GasN/AGBX 0.56-2.6%N/A-35.3%£5.37M£3.57M-0.792,850Gap UpSUNSurgical Innovations GroupN/AGBX 0.51-6.5%N/A+24.2%£4.80M£12.54M-21.1180Gap DownWRESW ResourcesN/AN/AN/AN/A£3.89M£3.47M-0.4366Gap DownEQTEQTECN/AGBX 0.65+4.0%N/A-63.8%£1.67M£3.85M-3.82740Gap UpCRCCircle PropertyN/AN/AN/AN/A£1.02M£7.57M50.001,060Gap DownHigh Trading VolumeWEBWebisN/AN/AN/AN/A£157,000.00£49.70M14.1350Gap DownNBL18564 (NBL.L)N/AN/AN/AN/A£0.00N/A0.002,330FTO2059984 (FTO.L)N/AN/AN/AN/A£0.00N/A0.00147,000TXO282082 (TXO.L)N/AN/AN/AN/A£0.00N/A0.00170 Related Companies and Tools Related Companies Highlands Natural Resources Alternatives Europa Oil & Gas Alternatives Surgical Innovations Group Alternatives W Resources Alternatives EQTEC Alternatives Circle Property Alternatives Webis Alternatives 18564 (NBL.L) Alternatives 2059984 (FTO.L) Alternatives 282082 (TXO.L) Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (LON:VAL) was last updated on 5/2/2025 by MarketBeat.com Staff From Our PartnersWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | SponsoredTrump to redistribute trillions of dollars Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredMusk's warning signal: Prepare before the cascade beginsWhen Elon Musk triggered his AI layoff plan, most analysts missed what it really meant. Louis Navellier didn’t...InvestorPlace | SponsoredElon Musk is all in on these robots …Robots — built by Nvidia. Forbes says this could be " a $24 trillion opportunity for investors." Huang s...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ValiRx plc Please log in to your account or sign up in order to add this asset to your watchlist. Share ValiRx With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
